Results 161 to 170 of about 1,911,944 (302)

High‐Resolution Deep Learning Dixon Magnetic Resonance Imaging of the Sacroiliac Joints Is Noninferior to Standard Magnetic Resonance Imaging in Patients With Suspected Axial Spondyloarthritis

Arthritis &Rheumatology, EarlyView.
Objective To compare the multisequence standard magnetic resonance imaging (sMRI) protocol of the sacroiliac joints with a single high‐resolution deep learning–reconstructed Dixon sequence (DL‐Dixon) in patients with suspected axial spondyloarthritis (axSpA). Methods Seventy‐six patients with chronic low back pain and suspected axSpA underwent clinical,
Dominik Deppe, Mariam Koka, Fabian Proft, Sevtap Tugce Ulas, Kay‐Geert Hermann, Denis Poddubnyy, Mikhail Protopopov, Henriette Baum, Hildrun Haibel, Mehrgan Shahryari, Valeria Rios Rodriguez, Jens Vogel‐Claussen, Torsten Diekhoff   +12 more
wiley   +1 more source

The neurobiological regulatory mechanism of brain edema. [PDF]

Front Cell Neurosci
Tian M, Li M, Zhang C, Luo Q, Wang A, Li D.   +5 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Spontaneous regression of peritumoral brain edema in an asymptomatic meningioma: A radiological case report. [PDF]

Radiol Case Rep
Takahashi T, Yanaka K, Aiyama H, Maruyama S, Takahashi N, Marushima A, Ishikawa E.   +6 more
europepmc   +1 more source

Brain Edema in Developing Brain Diseases

, 2017
Brain edema was initially defined as an increase in net brain water content leading to an increase in tissue volume. Extensive research has led to a more accurate definition, including pathophysiological characteristics such as molecular, cellular ...
Raffaella Moretti (3425231), Pierre Gressens (104878), Luigi Titomanilo (19989069), Vibol Chhor (3413447), Bobbi Fleiss (18028750)   +4 more
core  

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Potentiation of GPR68 alleviates post-ischemia BBB dysfunction and brain edema in mice. [PDF]

Exp Neurol
Sun W, Fu W, Zhou Y, Tiwari V, Zha XM.
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Fenofibrate alleviates the brain edema after traumatic brain injury by enhancing endothelial OXPHOS. [PDF]

Redox Biol
Feng Q, Gao Y, Gu X, Zhao X, Liu X, Ma Z, Qi W, He Z, Han Y, Zhang J, Wang W, Li Z, Zhang D, Huang J, Lin Y, Hui J, Onondari B, Erdenetsetseg G, Mao Q, Jiang J, Zhou Y, Weng W, Zhang Y, Feng J.   +23 more
europepmc   +1 more source

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source